Cargando…
The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process
OBJECTIVE: This manuscript aims to provide an overview of the unique considerations and best practice principles associated with the manufacture of human viral challenge agents. RESULTS: Considerations are discussed on the entire process from strain and viral source selection through manufacturing,...
Autores principales: | Catchpole, Andrew P., Fullen, Daniel J., Noulin, Nicolas, Mann, Alex, Gilbert, Anthony S., Lambkin-Williams, Rob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114718/ https://www.ncbi.nlm.nih.gov/pubmed/30157933 http://dx.doi.org/10.1186/s13104-018-3636-7 |
Ejemplares similares
-
The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics
por: Lambkin-Williams, Rob, et al.
Publicado: (2018) -
Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model
por: Fullen, Daniel J., et al.
Publicado: (2016) -
Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model
por: Fullen, Daniel J., et al.
Publicado: (2016) -
A Tool for Investigating Asthma and COPD Exacerbations: A Newly Manufactured and Well Characterised GMP Wild-Type Human Rhinovirus for Use in the Human Viral Challenge Model
por: Fullen, Daniel J., et al.
Publicado: (2016) -
Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge
por: Mann, Alex J., et al.
Publicado: (2014)